Markets:

Overview

News

Currencies

International

Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

5.400 -0.900 (-14.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about EyePoint, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Gold Down Over 2%; US Factory Orders Fall In October ↗

December 04, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Monday. The Dow traded down 0.36% to 36,116.18 while the NASDAQ fell 1.19% to 14,134.99. The S&P 500...

Via Benzinga

Topics Stocks

Why Is EyePoint Pharmaceuticals (EYPT) Stock Up 187% Today? ↗

December 04, 2023

EyePoint Pharmaceuticals stock is rising higher with heavy trading of EYPT on Monday after posting positive results from a clinical trial.

Via InvestorPlace

Nasdaq Down Over 100 Points; Alaska Air To Acquire Hawaiian Airlines ↗

December 04, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.13% to 36,198.88 while the NASDAQ fell...

Via Benzinga

Topics Stocks

December 04, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced topline results of its Phase 2 DAVIO 2 trial of EYP-1901, an investigational sustained delivery maintenance treatment for wet age-related macular...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 04, 2023

Via Benzinga

Expert Ratings for EyePoint Pharmaceuticals ↗

November 02, 2023

Via Benzinga

Where EyePoint Pharmaceuticals Stands With Analysts ↗

July 28, 2023

Via Benzinga

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential ↗

December 03, 2023

Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing.

Via InvestorPlace

Mizuho's Top Stock Picks For November Revealed ↗

November 05, 2023

As trading for November begins, Mizuho recommends a few stocks for investors to consider.

Via Benzinga

Why Is Vision Disorder-Focused EyePoint Pharmaceuticals Stock Trading Higher Today? ↗

November 01, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q3 revenues of $15.20 million, up from $10 million a year ago and beating

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 28, 2023

Via Benzinga

Why Shares of EyePoint Pharmaceuticals Were Rising Monday ↗

September 11, 2023

The company reported positive trial data for its lead therapy to treat two different eye conditions.

Via The Motley Fool

What 6 Analyst Ratings Have To Say About EyePoint Pharmaceuticals ↗

June 28, 2023

Via Benzinga

5 Analysts Have This to Say About EyePoint Pharmaceuticals ↗

June 06, 2023

Via Benzinga

EyePoint Pharmaceuticals: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

Why's Going On With EyePoint Pharmaceuticals Stock Today? ↗

September 11, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced interim masked safety data for its lead product candidate EYP-1901 from its ongoing Phase 2 PAVIA trial of EYP-1901 as a potential nine-month...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

Why Are EyePoint Pharmaceuticals Shares Trading Higher Today ↗

July 10, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating

Via Benzinga

EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035 ↗

June 14, 2023

JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

Why Is Alimera Sciences (ALIM) Stock Up 21% Today? ↗

May 18, 2023

Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).

Via InvestorPlace

EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties ↗

May 18, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).

Via Benzinga

Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today ↗

May 03, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q1 revenues of $7.68 million, down from $9.3 million a year ago but slightly

Via Benzinga

R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

May 02, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

Via FinancialNewsMedia

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 24, 2023

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday ↗

April 24, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings ↗

April 21, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...

Via Benzinga

EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21

April 21, 2023

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.